Cargando…
Monoclonal Gammopathies and the Bone Marrow Microenvironment: From Bench to Bedside and Then Back Again
Multiple myeloma (MM) is an incurable hematologic malignancy characterized by a multistep evolutionary pathway, with an initial phase called monoclonal gammopathy of undetermined significance (MGUS), potentially evolving into the symptomatic disease, often preceded by an intermediate phase called “s...
Autores principales: | Plano, Federica, Corsale, Anna Maria, Gigliotta, Emilia, Camarda, Giulia, Vullo, Candida, Di Simone, Marta, Shekarkar Azgomi, Mojtaba, Speciale, Maria, Carlisi, Melania, Caccamo, Nadia, Dieli, Francesco, Meraviglia, Serena, Siragusa, Sergio, Botta, Cirino |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9844382/ https://www.ncbi.nlm.nih.gov/pubmed/36648882 http://dx.doi.org/10.3390/hematolrep15010004 |
Ejemplares similares
-
Ferritin Metabolism Reflects Multiple Myeloma Microenvironment and Predicts Patient Outcome
por: Plano, Federica, et al.
Publicado: (2023) -
B-Cell Receptor Signaling Is Thought to Be a Bridge between Primary Sjogren Syndrome and Diffuse Large B-Cell Lymphoma
por: Mohammadnezhad, Leila, et al.
Publicado: (2023) -
Editorial: Pharmacogenomics: From Bench to Bedside and Back Again
por: Shaman, Jeffrey A., et al.
Publicado: (2022) -
Biomarkers in Pediatric Nephrology—From Bedside to Bench and Back Again
por: Musiał, Kinga
Publicado: (2022) -
Molecular-Biology-Driven Frontline Treatment for Chronic Lymphocytic Leukemia: A Network Meta-Analysis of Randomized Clinical Trials
por: Rizzuto, Andrea, et al.
Publicado: (2023)